| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | Australia | 6 | |
| #3 | EPO (European Patent Office) | 5 | |
| #4 | Canada | 4 | |
| #5 | China | 4 | |
| #6 | WIPO (World Intellectual Property Organization) | 4 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Foods and drinks | |
| #4 | Environmental technology | |
| #5 | Measurement | |
| #6 | Machines |
| # | Name | Total Patents |
|---|---|---|
| #1 | Clark Mike A | 27 |
| #2 | Ensor Charles Mark | 7 |
| #3 | Holtsberg Frederick Wayne | 7 |
| #4 | Clark Mike | 2 |
| #5 | Mark Holtsberg Frederick Wayne | 1 |
| #6 | Ensor Charles M | 1 |
| #7 | Holtsberg Frederick W | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO02063048A2 | Methods for predicting sensitivity of tumors to arginine deprivation | |
| WO0244360A2 | Modified arginine deiminase | |
| US6913915B2 | PEG-modified uricase | |
| US6645739B2 | Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same | |
| AU5935301A | Novel mutated form of arginine deiminase | |
| AU7479898A | Modified arginine deiminase | |
| CA2277757A1 | Modified tumor necrosis factor |